Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives

The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Fernandes, Neha Benedicta [verfasserIn] Nayak, Yogendra [verfasserIn] Garg, Sanjay [verfasserIn] Nayak, Usha Y [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2022

Schlagwörter:	Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles

Übergeordnetes Werk:	Enthalten in: Coordination chemistry reviews - Amsterdam [u.a.] : Elsevier Science, 1966, 478
Übergeordnetes Werk:	volume:478

DOI / URN:	10.1016/j.ccr.2022.214977

Katalog-ID:	ELV009051309

Internformat


LEADER	01000caa a22002652 4500
001	ELV009051309
003	DE-627
005	20230524142741.0
007	cr uuu---uuuuu
008	230510s2022 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/j.ccr.2022.214977 \|2 doi
035			\|a (DE-627)ELV009051309
035			\|a (ELSEVIER)S0010-8545(22)00572-0
040			\|a DE-627 \|b ger \|c DE-627 \|e rda
041			\|a eng
082	0	4	\|a 540 \|q DE-600
084			\|a 35.00 \|2 bkl
100	1		\|a Fernandes, Neha Benedicta \|e verfasserin \|4 aut
245	1	0	\|a Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives
264		1	\|c 2022
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives.
650		4	\|a Nanotheranostics
650		4	\|a Biocompatibility
650		4	\|a Biodegradability
650		4	\|a Multifunctional systems
650		4	\|a Mesoporous silica nanoparticles
650		4	\|a Upconversion nanoparticles
700	1		\|a Nayak, Yogendra \|e verfasserin \|4 aut
700	1		\|a Garg, Sanjay \|e verfasserin \|4 aut
700	1		\|a Nayak, Usha Y \|e verfasserin \|4 aut
773	0	8	\|i Enthalten in \|t Coordination chemistry reviews \|d Amsterdam [u.a.] : Elsevier Science, 1966 \|g 478 \|h Online-Ressource \|w (DE-627)306655020 \|w (DE-600)1499984-5 \|w (DE-576)081985002 \|x 0010-8545 \|7 nnns
773	1	8	\|g volume:478
912			\|a GBV_USEFLAG_U
912			\|a SYSFLAG_U
912			\|a GBV_ELV
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_101
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_150
912			\|a GBV_ILN_151
912			\|a GBV_ILN_224
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2050
912			\|a GBV_ILN_2056
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2065
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2122
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2336
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_2522
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4393
936	b	k	\|a 35.00 \|j Chemie: Allgemeines
951			\|a AR
952			\|d 478

Indexfelder

author_variant	n b f nb nbf y n yn s g sg u y n uy uyn
matchkey_str	article:00108545:2022----::utfntoaegneemspruslciogncaeilyrdaoatc
hierarchy_sort_str	2022
bklnumber	35.00
publishDate	2022
allfields	10.1016/j.ccr.2022.214977 doi (DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 DE-627 ger DE-627 rda eng 540 DE-600 35.00 bkl Fernandes, Neha Benedicta verfasserin aut Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles Nayak, Yogendra verfasserin aut Garg, Sanjay verfasserin aut Nayak, Usha Y verfasserin aut Enthalten in Coordination chemistry reviews Amsterdam [u.a.] : Elsevier Science, 1966 478 Online-Ressource (DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 0010-8545 nnns volume:478 GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.00 Chemie: Allgemeines AR 478
spelling	10.1016/j.ccr.2022.214977 doi (DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 DE-627 ger DE-627 rda eng 540 DE-600 35.00 bkl Fernandes, Neha Benedicta verfasserin aut Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles Nayak, Yogendra verfasserin aut Garg, Sanjay verfasserin aut Nayak, Usha Y verfasserin aut Enthalten in Coordination chemistry reviews Amsterdam [u.a.] : Elsevier Science, 1966 478 Online-Ressource (DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 0010-8545 nnns volume:478 GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.00 Chemie: Allgemeines AR 478
allfields_unstemmed	10.1016/j.ccr.2022.214977 doi (DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 DE-627 ger DE-627 rda eng 540 DE-600 35.00 bkl Fernandes, Neha Benedicta verfasserin aut Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles Nayak, Yogendra verfasserin aut Garg, Sanjay verfasserin aut Nayak, Usha Y verfasserin aut Enthalten in Coordination chemistry reviews Amsterdam [u.a.] : Elsevier Science, 1966 478 Online-Ressource (DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 0010-8545 nnns volume:478 GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.00 Chemie: Allgemeines AR 478
allfieldsGer	10.1016/j.ccr.2022.214977 doi (DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 DE-627 ger DE-627 rda eng 540 DE-600 35.00 bkl Fernandes, Neha Benedicta verfasserin aut Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles Nayak, Yogendra verfasserin aut Garg, Sanjay verfasserin aut Nayak, Usha Y verfasserin aut Enthalten in Coordination chemistry reviews Amsterdam [u.a.] : Elsevier Science, 1966 478 Online-Ressource (DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 0010-8545 nnns volume:478 GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.00 Chemie: Allgemeines AR 478
allfieldsSound	10.1016/j.ccr.2022.214977 doi (DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 DE-627 ger DE-627 rda eng 540 DE-600 35.00 bkl Fernandes, Neha Benedicta verfasserin aut Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles Nayak, Yogendra verfasserin aut Garg, Sanjay verfasserin aut Nayak, Usha Y verfasserin aut Enthalten in Coordination chemistry reviews Amsterdam [u.a.] : Elsevier Science, 1966 478 Online-Ressource (DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 0010-8545 nnns volume:478 GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.00 Chemie: Allgemeines AR 478
language	English
source	Enthalten in Coordination chemistry reviews 478 volume:478
sourceStr	Enthalten in Coordination chemistry reviews 478 volume:478
format_phy_str_mv	Article
bklname	Chemie: Allgemeines
institution	findex.gbv.de
topic_facet	Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles
dewey-raw	540
isfreeaccess_bool	false
container_title	Coordination chemistry reviews
authorswithroles_txt_mv	Fernandes, Neha Benedicta @@aut@@ Nayak, Yogendra @@aut@@ Garg, Sanjay @@aut@@ Nayak, Usha Y @@aut@@
publishDateDaySort_date	2022-01-01T00:00:00Z
hierarchy_top_id	306655020
dewey-sort	3540
id	ELV009051309
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV009051309</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230524142741.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230510s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ccr.2022.214977</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV009051309</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0010-8545(22)00572-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fernandes, Neha Benedicta</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanotheranostics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biocompatibility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biodegradability</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multifunctional systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mesoporous silica nanoparticles</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Upconversion nanoparticles</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nayak, Yogendra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garg, Sanjay</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nayak, Usha Y</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Coordination chemistry reviews</subfield><subfield code="d">Amsterdam [u.a.] : Elsevier Science, 1966</subfield><subfield code="g">478</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)306655020</subfield><subfield code="w">(DE-600)1499984-5</subfield><subfield code="w">(DE-576)081985002</subfield><subfield code="x">0010-8545</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:478</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_101</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_150</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2049</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2065</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2113</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2118</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2522</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">478</subfield></datafield></record></collection>
author	Fernandes, Neha Benedicta
spellingShingle	Fernandes, Neha Benedicta ddc 540 bkl 35.00 misc Nanotheranostics misc Biocompatibility misc Biodegradability misc Multifunctional systems misc Mesoporous silica nanoparticles misc Upconversion nanoparticles Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives
authorStr	Fernandes, Neha Benedicta
ppnlink_with_tag_str_mv	@@773@@(DE-627)306655020
format	electronic Article
dewey-ones	540 - Chemistry & allied sciences
delete_txt_mv	keep
author_role	aut aut aut aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
issn	0010-8545
topic_title	540 DE-600 35.00 bkl Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles
topic	ddc 540 bkl 35.00 misc Nanotheranostics misc Biocompatibility misc Biodegradability misc Multifunctional systems misc Mesoporous silica nanoparticles misc Upconversion nanoparticles
topic_unstemmed	ddc 540 bkl 35.00 misc Nanotheranostics misc Biocompatibility misc Biodegradability misc Multifunctional systems misc Mesoporous silica nanoparticles misc Upconversion nanoparticles
topic_browse	ddc 540 bkl 35.00 misc Nanotheranostics misc Biocompatibility misc Biodegradability misc Multifunctional systems misc Mesoporous silica nanoparticles misc Upconversion nanoparticles
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Coordination chemistry reviews
hierarchy_parent_id	306655020
dewey-tens	540 - Chemistry
hierarchy_top_title	Coordination chemistry reviews
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002
title	Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives
ctrlnum	(DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0
title_full	Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives
author_sort	Fernandes, Neha Benedicta
journal	Coordination chemistry reviews
journalStr	Coordination chemistry reviews
lang_code	eng
isOA_bool	false
dewey-hundreds	500 - Science
recordtype	marc
publishDateSort	2022
contenttype_str_mv	zzz
author_browse	Fernandes, Neha Benedicta Nayak, Yogendra Garg, Sanjay Nayak, Usha Y
container_volume	478
class	540 DE-600 35.00 bkl
format_se	Elektronische Aufsätze
author-letter	Fernandes, Neha Benedicta
doi_str_mv	10.1016/j.ccr.2022.214977
dewey-full	540
author2-role	verfasserin
title_sort	multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: theranostic perspectives
title_auth	Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives
abstract	The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives.
abstractGer	The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives.
abstract_unstemmed	The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives.
collection_details	GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393
title_short	Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives
remote_bool	true
author2	Nayak, Yogendra Garg, Sanjay Nayak, Usha Y
author2Str	Nayak, Yogendra Garg, Sanjay Nayak, Usha Y
ppnlink	306655020
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1016/j.ccr.2022.214977
up_date	2024-07-06T21:49:05.627Z
_version_	1803867962085474304
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV009051309</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230524142741.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230510s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ccr.2022.214977</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV009051309</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0010-8545(22)00572-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fernandes, Neha Benedicta</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanotheranostics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biocompatibility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biodegradability</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multifunctional systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mesoporous silica nanoparticles</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Upconversion nanoparticles</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nayak, Yogendra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garg, Sanjay</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nayak, Usha Y</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Coordination chemistry reviews</subfield><subfield code="d">Amsterdam [u.a.] : Elsevier Science, 1966</subfield><subfield code="g">478</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)306655020</subfield><subfield code="w">(DE-600)1499984-5</subfield><subfield code="w">(DE-576)081985002</subfield><subfield code="x">0010-8545</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:478</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_101</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_150</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2049</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2065</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2113</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2118</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2522</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">478</subfield></datafield></record></collection>
score	7.4004374

Nicht das Richtige dabei?

Schreiben Sie uns!

Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?